The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
100
PEP005 Gel 0.05% for 2 consecutive days
PEP005 Gel 0.015% for 3 consecutive days
TKL Research
Paramus, New Jersey, United States
Local Skin Responses
Time frame: Up to 8 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.